Keros Therapeutics Inc (KROS)
11.23
-0.36
(-3.11%)
USD |
NASDAQ |
Mar 05, 11:46
Keros Therapeutics Enterprise Value: -89.82M for March 4, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Intuitive Surgical Inc | 195.08B |
| Aptevo Therapeutics Inc | -4.412M |
| Corcept Therapeutics Inc | 5.524B |
| Spyre Therapeutics Inc | 810.63M |
| Trevi Therapeutics Inc | 275.02M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -46.03M |
| Revenue (Quarterly) | 3.042M |
| Total Expenses (Quarterly) | 55.06M |
| EPS Diluted (Quarterly) | -1.14 |
| Profit Margin (Quarterly) | -1.51K% |
| Earnings Yield | -44.61% |
| Normalized Earnings Yield | -50.20 |